focus -WSS

focus

author：Wikipedia 2025-09-30 22:22:28 - browse：5424

Axovant Sciences(AXON) is the main event in biotech’s September cavalcade of clinical trial readouts, but while we wait, it’s a good idea to prep for important — and stock-moving — data releases from Zogenix(ZGNX) and Amicus Therapeutics(FOLD).

Zogenix’s lead drug, called ZX008, is a low-dose liquid formulation of the old serotonin booster fenfluramine. The company is developing ZX008 to treat children with Dravet syndrome, a rare and severe type of epilepsy.

You might remember fenfluramine as part of the “fen-phen” obesity regimen that was pulled from the market in 1997 because fenfluramine (at a higher dose) caused severe damage to people’s heart valves.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： In early work, researchers turn to CRISPR to treat Alzheimer's

leisure time

hotspot

WSS

AI can’t replace a physician’s gut feeling

Mitch McConnell episode has important public health takeaway

In early work, researchers turn to CRISPR to treat Alzheimer's

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

The high personal cost of affirmative action for Black doctors

Pence says 'crackpot lawyers' told Trump what he wanted to hear

knowledge

focus

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

At Orexo, a ‘turning point’ for everything but digital health

Dobbs anniversary: the lost opportunity of abortion as health care

Mitch McConnell episode has important public health takeaway

New air purifier tech could be key to improving indoor air quality

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

What does generative AI mean for health care? We asked experts

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Peter Hotez and the public health issue of online harassment

Mega Millions pot grows to $1.25 billion after no winner

focus

‘Oppenheimer’ and the risks of AI in health care

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

New safety details link Apellis eye drug to rare cases of blindness

Doctors find melanoma drugs effective against rare brain cancer

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Wildfire pollution widens asthma inequities on Long Island

knowledge

leisure time

hotspot

hotspot